New medications for dystonia

Clinical Neurology

Volumn 52, Issue 11, 2012, Pages 1074-1076

  Miyazaki, Yoshimichi ^a   Sato, Kenta ^a   Koizumi, Hidetaka ^a   Sako, Wataru ^a   Asanuma, Koutaro ^a   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Clonazepam; Dystonia; Levetiracetam; Trihexyphenidil; Zolpidem

Indexed keywords

ZOLPIDEM;

CONFERENCE PAPER; DRUG EFFICACY; DYSTONIA; HUMAN; MAJOR CLINICAL STUDY; OPEN STUDY; TREATMENT RESPONSE;

ANTICONVULSANTS; DYSTONIA; GABA-A RECEPTOR AGONISTS; HUMANS; PIRACETAM; PYRIDINES;

EID: 84879593714     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.52.1074     Document Type: Conference Paper

References (9)

1. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255-1261.
2. Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol 1988;50:547-556.
3. Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2011;18:5-18.
4. Daniele A, Albanese A, Gainotti G, et al. Zolpidem in Parkinson's disease. Lancet 1997;349:1222-1223.
5. Miyazaki Y, Sako W, Asanuma K, et al. Efficacy of zolpidem for dystonia: a study among different subtypes. Front Neurol 2012;3:58.
6. Chen L, Savio CC, Young WH. Electrophysiological and behavioral effects of zolpidem in rat globus pallidus. Experimental Neurology 2004;186:212-220.
7. Levy LM, Hallett M. Impaired brain GABA in focal dystonia. Ann Neurol 2002;51:93-101.
8. Löscher W, Richter A. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia. Eur J Pharmacol 2000;391:251-254.
9. Hering S, Wenning GK, Seppi K, et al. An open trial of levetiracetam for segmental and generalized dystonia. Mov Disord 2007;22:1649-1651.